tfr with nilotinib in cml: enestfreedom and enestop
Published 6 years ago • 379 plays • Length 6:41Download video MP4
Download video MP3
Similar videos
-
1:50
dr. donnellan on tfr in patients with cml treated with nilotinib
-
2:36
update on enestop: tfr in cml after discontinuing nilotinib
-
1:43
dr. hochhaus on tfs with nilotinib in patients with cml
-
1:33
enestop: deep molecular response in cml can be translated into treatment-free remission
-
5:49
tidel-ii: switching from imatinib to nilotinib in cml
-
2:44
cml tfr criteria / chronic myeloid leukemia treatment free remission / tki discontinuation/cessation
-
5:17
2 years of tfr for cml / treatment free remission / chronic myeloid leukemia / tasigna (nilotinib)
-
8:16
cml treatment free remission/stopping tasigna (nilotinib)/chronic myeloid leukemia cessation/cml tfr
-
2:03
nilotinib benefits relapsed patients with cml after treatment discontinuation
-
1:40
dr. timothy hughes compares imatinib to nilotinib in chronic myeloid leukemia
-
7:50
chronic myeloid leukemia: selecting patients for tfr
-
2:05
tasigna and low blood cell counts / tasigna side effects / cml / low wbc / nilotinib
-
1:41
jayshree shah on the safety and efficacy of nilotinib for patients with cml
-
4:54
achieving treatment-free remissions in cml
-
1:29:09
online webinar: treatment free remission (tfr) in chronic myeloid leukaemia (cml)
-
3:18
predictors for tfr in cml: response duration, secondary treatment & frontline tki choice
-
1:22
examples of challenging scenarios for tfr in cml & how to manage them